Christoph U Correll
Overview
Explore the profile of Christoph U Correll including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
869
Citations
24045
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Solmi M, Basadonne I, Bodini L, Rosenbaum S, Schuch F, Smith L, et al.
J Psychiatr Res
. 2025 Mar;
184:91-101.
PMID: 40043589
Exercise is beneficial for mental health in general, but no review has systematically assessed its potential transdiagnostic nature, i.e. whether it is beneficial across specific disorders. We performed a systematic...
2.
Lieslehto J, Tiihonen J, Lahteenvuo M, Kautzky A, Akhtar A, Armannsdottir B, et al.
EClinicalMedicine
. 2025 Mar;
81:103108.
PMID: 40034574
Background: Accurate mortality risk prediction could enhance treatment planning in bipolar disorder, where mortality rates rival those of many cancers. Such prognostic tools are lacking in psychiatry, where assessments typically...
3.
Schoretsanitis G, Correll C
Expert Opin Drug Metab Toxicol
. 2025 Feb;
:1-9.
PMID: 40017334
Introduction: Risperidone-ISM is a novel intramuscular long-acting injectable formulation (LAI) of risperidone approved for the treatment of schizophrenia in adults. Knowledge regarding the pharmacokinetic properties of risperidone-ISM can improve care....
4.
Tiihonen J, Tanskanen A, Solmi M, Rubio J, Correll C, Kane J, et al.
Am J Psychiatry
. 2025 Feb;
PMID: 39967411
Objective: It is not known what proportion of patients experience relapse in first-episode schizophrenia despite continuous dopamine D receptor blockade and whether breakthrough psychosis is attributable to long-term use of...
5.
Glaus J, Karow A, Lambert M, Sowada P, Brockel-Bundt K, Berndt C, et al.
Int J Bipolar Disord
. 2025 Feb;
13(1):7.
PMID: 39964389
Background: Improving quality of life (QoL) is important for the treatment of people with bipolar disorder (BD). Early-BipoLife is a German multicentre naturalistic, prospective-longitudinal observational cohort study investigating early recognition...
6.
Fabiano N, Wong S, Zhou C, Correll C, Hojlund M, Solmi M
Eur Neuropsychopharmacol
. 2025 Feb;
94:17-18.
PMID: 39961191
No abstract available.
7.
Fritze S, Brandt G, Volkmer S, Daub J, Altinok D, Kubera K, et al.
Schizophrenia (Heidelb)
. 2025 Feb;
11(1):16.
PMID: 39939637
Sensori- and psychomotor abnormalities are an inherent part of schizophrenia-spectrum disorders (SSD) pathophysiology and linked to psychopathological symptoms as well as cognitive and global functioning. However, how these different symptom...
8.
Chan J, Solmi M, Correll C, Wong C, Lo H, Lai F, et al.
JAMA Netw Open
. 2025 Feb;
8(2):e2458608.
PMID: 39932712
Importance: Literature indicates adverse effects of lithium on thyroid and kidney function. However, existing data are heterogeneous, with limitations in quality and lack evaluation of adverse effects of lithium vs...
9.
Ermis C, Taipale H, Tanskanen A, Vieta E, Correll C, Mittendorfer-Rutz E, et al.
Lancet Psychiatry
. 2025 Feb;
12(3):198-207.
PMID: 39922213
Background: Long-term add-on antidepressant use for bipolar depression remains controversial. This study aimed to investigate primarily the association between psychopharmacological treatments and hospitalisation (ie, hospital admission) for bipolar depression, and...
10.